However, Michael et al. (2019) discovered that the downregulation of SORL1 expression facilitates tumor growth in a transplant tumor model and relatively low expression predicts a worse prognosis in human breast, lung, and gastric cancer patients. The gene discussed is SORL1; the disease is gastric cancer.